Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|September 13, 2023
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancerRobert Hsu, Denaly Chen, Bing Xia, et al.Science Translational Medicine|January 18, 2019
Tuberculosis following PD-1 blockade for cancer immunotherapyDaniel L Barber, Shunsuke Sakai, Ragini R Kudchadkar, et al.Cancers|August 27, 2021
Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGENTM): Early Clinical ResultsFrederic Ris, Minia Hellan, Jonathan Douissard, et al.Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.JCO Clinical Cancer Informatics|September 24, 2020
Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care EncountersTanachat Nilanon, Luciano P Nocera, Alexander S Martin, et al.British Journal of Cancer|September 4, 2021
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer typesChristian Rolfo, Alexander Drilon, David Hong, et al.Molecular Cancer Therapeutics|September 14, 2021
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung CancerJulia Judd, Nagla Abdel Karim, Hina Khan, et al.JCO Precision Oncology|February 8, 2024
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.Pageof 5